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ABSTRACT
We previously proposed that colonizing strains of E. coli likely occupy
specific niches as minimal members of mixed biofilms formed primarily by anaerobic
members of the gut flora. These “restaurants” formed by the different community
members of the gut provide individual strains of E. coli with various unique binding
pockets and locally provided mono- and disaccharides by breaking down
polysaccharides which facultative anaerobes, such as E. coli, could not break down on
their own. This allows strains of E. coli that cannot grow as efficiently on available
sugars to colonize if they are able to occupy niches that other competing strains could
not. For example, if the less efficient strain could bind better to specific anaerobic
members or had a higher tolerance for bile salts it would be able to co-colonize with a
strain that could grow better on available sugars as it would not be in direct
competition to occupy the same niche. While the anaerobes in mixed biofilms provide
a source of nutrients for minimal members such as E. coli through breakdown of large
polysaccharides, the facultative anaerobes may improve the environment for strict
anaerobes by reducing the concentration of oxygen within the biofilms. Oxygen
diffuses from surrounding tissue into the intestines, oxygen from swallowed air is
present in flatus, and at least one predominant anaerobe in the gut microbiome,
Bacteroides fragilis, respires oxygen at low concentrations. As such, manuscript I
looks at how colonization with specific strains of E. coli can affect the development of
the intestinal microbiota. Five representative E. coli strains were used for this study:
Nissle 1917, EDL933, MG1655, and two MG1655 mutants selected by the mouse gut
(envZ

P41L

and flhDC). While slight variances were observed between strains, these

were likely due to differences between hosts rather than the colonizing E. coli and no
significant differences between the communities could be surmised.
In order to better understand the interactions between E. coli and the members
of the intestinal microbiota, a novel in vitro method was developed. Manuscript II
examines the development of the in vitro system as it was compared to the mouse
model. This method was designed to be simple and inexpensive while providing an
environment meant to replicate the natural habitat of these organisms: the mammalian
gut. The current study examines the development of said in vitro model and its ability
to mimic the mouse gut in terms of diversity of organisms, as well as its usefulness in
examining the colonizing ability of competing E. coli strains. It is shown that, while
still in development, this system is currently able to maintain diversity comparable to
what is seen in mice.

While the abundance of these diverse organisms is not

necessarily at the levels seen in mice, the model is already an effective system for
studying the microbial community of the gut in a controlled environment.
Furthermore, the system is able to mimic certain colonization experiments of
competing E. coli strains done in mice, and with improvements to bolster the growth
of the diverse population could be used as a non-invasive method for studying gut
microbes.
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PREFACE
This dissertation has been prepared in the Manuscript Format according to the
guidelines of the Graduate School of the University of Rhode Island with the style
presented in the American Society for Microbiology journal, Infection and Immunity.
The dissertation includes an introduction and the following two manuscripts:
The first manuscript: “Analysis of how Different Strains of Escherichia coli
Affect Development of the Intestinal Microbiota”
The second manuscript: “Developing an In Vitro Method for Studying the
Interaction between E. coli and the Intestinal Microbiota”
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LITERATURE REVIEW
Introduction
The human intestinal tract is known to maintain a diverse population of
microorganisms represented by both anaerobic and facultative anaerobic species (10).
It is well known that commensal strains of E. coli colonize as a minority member of
these communities as a facultative anaerobe (22).

Commensal strains include

organisms that naturally inhabit a host organism’s body without causing harm, and in
some cases even providing the host with a particular advantage (21). In contrast, a
pathogenic strain is usually an invasive organism that may be of the same species,
such as E. coli EDL933, but disease is caused rather than a harmless coexistence (21).
From ingestion to colonization
When a host ingests E. coli from the environment the E. coli must be able to
pass the acid barrier of the stomach, as well as be able to attain the nutrients necessary
to begin logarithmic growth. As stationary phase bacteria are acid-tolerant (14), as
few as 10 E. coli cells can lead to transmission (24). In order to exit lag phase and
begin logarithmic growth upon reaching the colon, E. coli must compete for nutrients
with a dense community (15), be able to penetrate into the mucus layer (31), and grow
rapidly enough to make up for the constant turnover of the mucus layer (37) all while
avoiding host defenses (7, 29). When successful in colonizing the colon, some E. coli
cells are still removed with the turnover of mucus. These cells are able to re-enter the
environment where they can be ingested by the next host, and thus spread and
continue to exist (34, 35).
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Basic principles of colonization
According to Freter’s nutrient-niche hypothesis, colonizing strains can coexist
as long as they are able to outcompete one another on one or more sugars, or are able
to bind to the intestinal wall. Thus if two strains (X and Y) are in direct competition
and (X) can utilize all sugars better than (Y), then the less efficient strain (Y) cannot
co-colonize (11).

This hypothesis assumes that all available nutrients are

homogenized, or equally mixed, throughout the intestine (15). As such, a diverse and
stable community would hinder invading species and prevent them from colonizing.
This ability to prevent invasion from outside species is called “colonization resistance”
(41). Even with this in mind, E. coli strains can coexist due to diverse strategies for
the utilization of limited nutrients within the colon.
Central metabolism and intestinal colonization
E. coli is a Gram-negative, prototrophic, facultative anaerobe. While E. coli
grows best on sugars it cannot grow on larger polysaccharides, as it does not have the
enzymes available to do so (12). It can also grow on substrates that feed into the TCA
cycle, which require gluconeogenesis to metabolize.

Other important central

metabolism pathways in E. coli include the Embden-Meyerhof-Parnas glycolytic
pathway (EMP), the pentose phosphate pathway (PP), the Entner-Duodoroff pathway
(ED), and many fermentation pathways all of which are highly conserved (9).
Catabolic pathway diversity in E. coli
While the central metabolism genes are highly conserved across strains of E.
coli, there is variation between strains in terms of the catabolic pathways that feed into
these core central metabolism pathways (9, 32). In other words, some E. coli strains
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have different preferences in terms of growth on sugars or other substrates. It has
been shown that while E. coli strains have similar catabolic potential, the sugars each
strain uses to support their colonization differs significantly (5, 8, 12, 20, 28, 30, 39).
Nutrient availability in the intestine
Mucus in the gut exists in two forms, the loose layer and the firm layer (19).
The loose mucus layer is where most of the microbiota of the gut grow and form their
biofilms, while the firm mucus layer resides closer to the epithelial layer of the
intestines and prevents direct interaction of the commensal microbiota with host
epithelium (19). The mucus itself consists of a large mixture of molecules, including
but not limited to amino acids, large polysaccharides, mono- and disaccharides, and
mucin (4).

This mixture exists as a viscous liquid in which the microbes are

suspended and in which form biofilms. This environment is mostly anaerobic, with
minimal oxygen leaking from epithelial cells of the intestine (6, 16, 18, 23). Mucin is
a glycoprotein with large polysaccharide strands with which the anaerobe populations
of the gut can attach and form biofilms around (2). The biofilms formed by these
anaerobes can break down the large polysaccharides of the mucus, and parts of the
mucin, thus providing facultatives with usable mono- and disaccharides in bulk which
would usually be limited (22, 33, 40). This gives facultatives, such as E. coli, a reason
for joining as minimal members in these anaerobe-formed biofilms, and perhaps even
promoting the growth of preferential anaerobes that provide specific mono- and
disaccharides (18). The facultatives that join these mixed biofilms likely provide the
anaerobes with protection from the minimal amount of oxygen that is released from
the epithelial tissue of the gut.
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Competition for limited nutrients in the intestine
In order to compete for limiting resources in the intestine, E. coli is able to
expand their transcriptome in order to induce a broad set of gene systems used for
carbon-source transport and catabolism (17). Additionally, it has been shown that
glycogen stores are used for survival during times of carbon limitation and are also
important for colonizing E. coli strains when colonizing the intestine (20).

By

expanding the gene systems used for carbon-source transport and catabolism, E. coli is
able to use a diverse set of sugars and can use nutrients that are available which no
other member of the microbiota has used.

A specific E. coli strain can also

outcompete other strains by growing faster on the available nutrients (13).
Furthermore, if an E. coli strain is being outcompeted for its preferred nutrients it will
activate other mechanisms in which it is no longer in direct competition (i.e. switching
to use other available sugars or pathways such as gluconeogenesis) (3, 5, 28, 38).
Finally, if a strain is able to enter a niche in which it forms a symbiotic relationship
(i.e. in a mixed anaerobic biofilm) that provides its preferred sugar(s), it will be able to
colonize away from direct competition with faster growing strains (1, 22).
Biofilms in the intestine
It has been shown that biofilms form in the mucus layers of the large intestines
of healthy mammals (25, 26, 33, 40). Furthermore, biofilms containing Bacteroides,
Enterobacter, and Clostridia species found in the intestine can form rapidly on mucin
in continuous flow culture systems developed to mimic the human intestine (27), thus
being able to develop faster than the flow of mucus (36). Recent studies of these
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms

4

with E.coli as a minority member (22). These biofilms form around intestinal mucin
and break down large polysaccharides, such as fiber, that cannot usually be utilized by
facultative anaerobes (22, 33, 40). Differences in the population of anaerobes within
mixed biofilms would thus provide E. coli with various niches based on nutrients
made available by the anaerobes preferred metabolic pathways.
The “restaurant” hypothesis
Our laboratory previously proposed an adjustment to the Freter’s hypothesis
which states that the mono- and disaccharides that E. coli strains use for growth in the
intestine are made available locally from polysaccharide degradation by the anaerobes
in the mixed biofilms that the E.coli inhabit, rather than evenly mixed throughout the
intestine. Furthermore, if one strain can bind better to the anaerobes in the mixed
biofilms, the colonization ability of this strain would be improved. Recent studies of
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms
with E.coli as a minority member (22). These biofilms form around intestinal mucin
and break down large polysaccharides, such as fiber, that cannot usually be utilized by
facultative anaerobes (22, 33, 40). Differences in the population of anaerobes within
mixed biofilms would thus provide E. coli with various niches based on nutrients
made available by the anaerobes preferred metabolic pathways.
While the anaerobes in mixed biofilms provide a source of nutrients for
minimal members such as E. coli through breakdown of large polysaccharides, the
facultative anaerobes may improve the environment for strict anaerobes by reducing
the concentration of oxygen within the biofilms. Oxygen diffuses from surrounding
tissue into the intestines, oxygen from swallowed air is present in flatus, and at least
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one predominant anaerobe in the gut microbiome, Bacteroides fragilis, respires
oxygen at low concentrations (6, 16, 18, 23). It has been shown that respiration in E.
coli provides an important competitive edge when colonizing the intestine of
streptomycin-treated mice. Mutants of ATP synthase or cytochrome bd oxidase, both
necessary for respiration, showed a significant loss in colonizing ability when
colonized against wild type of the same strain (18). Since E. coli uses oxygen as the
final electron-acceptor in respiration, the oxygen concentration within the intestine
will be lower in the presence of E. coli.
Conclusions
While E. coli is only a minimal member of a large and dense microbial
community found within the gut, it is still able to colonize and compete with such
diversity even when co-colonized with other strains of E. coli. It is likely that the
relationships formed by colonizing E. coli strains within dense anaerobe-formed
biofilms help develop unique niches not only for the E. coli, but also for the anaerobes
that are in direct interaction with them. Understanding how such a minor member is
able to overcome such complexity, as well as the effects on the community it causes,
is key to identifying mechanisms utilized by commensal and pathogenic bacteria to
invade and colonize new hosts. As such, this thesis aims to identify the effects of
colonization by various strains of E. coli and the effects they have on the overall
intestinal microbiota. Furthermore, the development of a novel in vitro system used to
aid in further understanding these relationships is discussed.
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MANUSCRIPT I
Analysis of how Different Strains of Escherichia coli Affect Development of the
Intestinal Microbiota
Abstract
We previously proposed that colonizing strains of E. coli likely occupy specific
niches as minimal members of mixed biofilms formed primarily by anaerobic
members of the gut flora. These “restaurants” formed by the different community
members of the gut provide individual strains of E. coli with various unique binding
pockets and locally provide mono- and disaccharides. This allows strains of E. coli
that cannot grow as efficiently on available sugars to colonize if they are able to
occupy niches that other competing strains could not. For example, if the less efficient
strain could bind better to specific anaerobic members or had a higher tolerance for
bile salts it would be able to co-colonize with a strain that could grow better on
available sugars as it would not be in direct competition to occupy the same niche.
As such, this study looks at how colonization with specific strains of E. coli can affect
the development of the intestinal microbiota. Five representative E. coli strains were
used for this study: Nissle 1917, EDL933, MG1655, and two MG1655 mutants
selected by the mouse gut (envZP41L and flhDC). While slight variances were observed
between strains, these were likely due to differences between hosts rather than the
colonizing E. coli and no significant differences between the communities could be
surmised.
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Introduction
The human intestinal tract is known to maintain a diverse population of
microorganisms represented by both anaerobic and facultative anaerobic species (11,
12). It is well known that commensal strains of E. coli colonize as a minority member
of these communities as a facultative anaerobe (27). Commensal strains include
organisms that naturally inhabit a host organism’s body without causing harm, and in
some cases even providing the host with a particular advantage (25). In contrast, a
pathogenic strain is usually an invasive organism that may be of the same species,
such as E. coli EDL933, but disease is caused rather than a harmless coexistence (25).
To prevent infection by pathogens, probiotic strains that block or reduce the
colonizing ability of pathogenic strains can be used, such as E. coli Nissle 1917 (25).
Once colonized, a probiotic strain will fill the niche normally used by the pathogenic
strain, preventing the pathogen from settling in. According to Freter’s nutrient-niche
hypothesis, colonizing strains can coexist as long as they are able to outcompete one
another on one or more sugars, or are able to bind to the intestinal wall. Thus if two
strains (X and Y) are in direct competition and (X) can utilize all sugars better than
(Y), then the less efficient strain (Y) cannot co-colonize (15).

This hypothesis

assumes that all available nutrients are homogenized, or equally mixed, throughout the
intestine (15).
In order to compare the colonization ability of strains, mice are often used as a
model system. In order to test E.coli strains within animal models, the niches that are
already filled by normal flora must be cleared. If this is not done, any attempts at
colonization will fail, as the niches are filled by other facultative anaerobes (8). There
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are currently two accepted models for testing the colonization ability of commensal
strains in mice; the germ-free mouse model and the streptomycin treated mouse model
(9, 24). In germ-free mice, no microbiota are present. This allows colonization to
occur, but removes any relationships with anaerobes normally present as part of the
microbiome (19). The streptomycin-treated mouse model does leave much of the
population intact, while still clearing the facultative anaerobe population for
colonization to occur. In this way the streptomycin-treated mouse model is superior,
as relationships between anaerobes and the facultative anaerobes being tested are kept
mostly intact (19).
E. coli strain MG1655 is a common laboratory strain used to test colonization
ability. When colonized by said strain, the intestine selects for mutants with improved
colonization ability. These include a non-motile strain with a deletion in the flhDC
region, and a motile strain with a missense mutation in the envZ gene (16, 26, 27).
The flhDC operon is responsible for making the FlhD4C2 complex, which activates
transcription of class II flagellar genes and represses a number of metabolic genes,
including those involving sugar catabolism (14, 43, 44). The deletion in the flhDC
region removes the ability to produce this regulatory complex and has been shown to
improve growth when compared to the parent MG1655 in vitro on cecal mucus and
other available carbon sources normally found within the intestine (16, 26). The envZ
gene codes for the transmembrane osmolarity sensor protein EnvZ, a histidine kinase
that acts on the OmpR regulatory protein as both a kinase and a phosphatase. OmpRphosphate regulates a number of genes including: ompC, ompF, the sRNAs omrA and
omrB, and flhDC (13). The envZ missense mutant selected by the intestine, a P41L
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mutant (ccg to tcg), reduces the phosphatase activity of EnvZ which results in a higher
concentration of OmpR-phosphate (27).
hereafter called envZ

P41L,

In vitro the envZ missense mutation,

results in a faster growth rate on several sugars relative to

the parent MG1655 strain, and a slower growth rate relative to the flhDC deletion
mutant on almost all sugars. However, when grown in vitro on galactose, the envZP41L
strain is far superior to both the parent MG1655 and flhDC deletion strains (27).
The MG1655 envZP41L missense mutant strain was recently shown to have
improved colonization ability against the parent MG1655 strain and colonized as well
as the MG1655 flhDC deletion mutant (27). In accordance with Freter’s hypothesis,
the envZP41L and flhDC mutants should be able to co-colonize as both are able to grow
well on different sugars and as such are not in direct competition. As expected, when
both strains are simultaneously fed to mice in the same nubers (ie. 105 CFU per
mouse) these mutant strains grow up to 109 CFU/gram of feces and co-colonize
equally well thereafter. Also, when 1010 CFU of the flhDC mutant is fed to mice
along with 105 CFU of the envZP41L mutant, the envZP41L mutant is able to grow up in
the intestine and almost reach the level of the flhDC mutant (21). This again agrees
with Freter’s hypothesis, as the strains are not in direct competition for sugars.
However, when the 105 CFU of the flhDC mutant is fed to mice along with 1010 CFU
of envZ

P41L

mutant, the flhDC mutant is unable to grow up against the envZ

P41L

mutant (27). From these results, it can be inferred that there are at least two niches
filled by envZ

P41L

mutant with some selective force that prevents flhDC from

colonizing one of these niches, and that envZ
flhDC from growing up in the shared niche.
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P41L

mutant is somehow able to prevent

Our laboratory previously proposed an adjustment to the Freter’s hypothesis
which states that the mono- and disaccharides that E. coli strains use for growth in the
intestine are made available locally from polysaccharide degradation by the anaerobes
in the mixed biofilms that the E.coli inhabit, rather than evenly mixed throughout the
intestine. Furthermore, if one strain can bind better to the anaerobes in the mixed
biofilms, the colonization ability of this strain would be improved. Recent studies of
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms
with E.coli as a minority member (27). These biofilms form around intestinal mucin
and break down large polysaccharides, such as fiber, that cannot usually be utilized by
facultative anaerobes (27, 40, 53). Differences in the population of anaerobes within
mixed biofilms would thus provide E. coli with various niches based on nutrients
made available by the anaerobes preferred metabolic pathways. If a specific mixed
biofilm produced mostly galactose as a metabolic byproduct of polysaccharide
breakdown, then envZ

P41L

mutant would be provided with a significant competitive

edge over the flhDC deletion mutant in that biofilm.
Due to the increased levels of OmpR-phosphate in the MG1655 envZ P41L mutant,
the surface of the cells is different from both the parent MG1655 and the MG1655
flhDC mutants. OmpR-phosphate acts to upregulate two small RNAs (sRNAs), omrA
and omrB. These sRNAs are responsible for regulating outer membrane proteins by
binding to the mRNA and preventing translation. One of the targets of these sRNAs is
cirA, which produces a surface protein that binds colicin toxins produced by other
bacteria (5). The MG1655 envZ P41L mutant has shown increased resistance to colicin
V, a toxin produced by E. coli strain F-18, which could be representative of its
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resistance to other bacteriocins produced in certain mixed biofilms throughout the
intestine (27). OmpR-phosphate also directly down regulates the production of the
OmpF porin protein, which is known to transport bile salts into the cell. With this
reduction in OmpF, less bile salts can move into the cell, and MG1655 envZ P41L gains
increased resistance to bile salts (27). The flagella of MG1655 envZ

P41L

also remain

intact allowing the cells to remain motile and adding yet another difference in the
surface proteins of the MG1655 envZ

P41L

mutant vs. the MG1655 flhDC mutant.

These differences in outer surfaces could provide the MG1655 envZ

P41L

mutant with

an improved affinity towards members of the mixed biofilm niche where it is in direct
competition with the MG1655 flhDC mutant.

With better binding affinity the

MG1655 envZ P41L would have a lower washout rate than wildtype MG1655, allowing
it to compete equally with the faster growth rate of the MG1655 flhDC mutant on most
sugars. The improved resistance of MG1655 envZ

P41L

to certain toxic substances in

addition to improved binding affinity could increase the types of mixed biofilms with
which it could associate.
While the anaerobes in mixed biofilms provide a source of nutrients for minimal
members such as E. coli through breakdown of large polysaccharides, the facultative
anaerobes may improve the environment for strict anaerobes by reducing the
concentration of oxygen within the biofilms. Oxygen diffuses from surrounding tissue
into the intestines, oxygen from swallowed air is present in flatus, and at least one
predominant anaerobe in the gut microbiome, Bacteroides fragilis, respires oxygen at
low concentrations (2, 18, 21, 28). It has been shown that respiration in E. coli
provides an important competitive edge when colonizing the intestine of streptomycin-
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treated mice. Mutants of ATP synthase or cytochrome bd oxidase, both necessary for
respiration, showed a significant loss in colonizing ability when colonized against wild
type of the same strain (21). Since E. coli uses oxygen as the final electron-acceptor in
respiration, the oxygen concentration within the intestine will be lower in the presence
of E. coli.

Growth of anaerobes in close association with E. coli will be provided

with a more preferential environment through depletion of oxygen, which is toxic to
anaerobes. This will allow the anaerobes to provide a better niche for the E. coli
through increased breakdown of large polysaccharides, leading to a mutualistic
relationship in which both the anaerobes and E. coli in mixed biofilms benefit.
This study tested the hypothesis that the overall community structure of the gut
may be influenced, and altered, by colonization with varying strains of E. coli. Based
on the differing surface structures, binding affinities, and sugar preferences of the E.
coli strains discussed thus far, each strain might prefer a different “restaurant,” which
would then lead to the preferential growth of the anaerobe members of the specific
niche filled by each E. coli.
Materials and Methods
Bacterial strains:
Bacterial strains used in this study are listed in Table 1. The original E. coli K-12
strain was obtained from a stool sample from a convalescing diphtheria patient in Palo
Alto, CA, in 1922 (1). The sequenced E. coli MG1655 strain (CGSC 7740) was
derived from the original K-12 strain, having only been cured of the temperate
bacteriophage lambda and the F plasmid by means of UV light and acridine orange
treatment (3). It has an IS1 element in the flhDC promoter (14). E. coli Nissle 1917
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was originally isolated during World War I from a soldier who escaped a severe
outbreak of diarrhea (50). It has a beneficial effect on several types of intestinal
disorders, is well tolerated by humans, and has been marketed as a probiotic remedy
against intestinal disorders in several European countries since the 1920s (50). The
allelic exchange method described by Datsenko and Wanner (10) was used to
construct E. coli MG1655 StrR Δ flhDC::cam (Table 1), 546-bp deletion
encompassing region immediately downstream of ISI in regulatory region of flhD and
into flhD.

E. coli EDL933 is the prototype strain of enterohemorrhagic E. coli

(EHEC) O157:H7 (42).
Media and growth conditions:
LB broth-Lennox (DIFCO) was prepared as directed (20g/L in water) and
sterilized. The approximate formula of LB broth Lennox (DIFCO) is listed as follows:
10g/L tryptone, 5g/L yeast extract, 5g/L sodium chloride. Bottles containing 10 ml of
LB broth Lennox (DIFCO) were inoculated with an individual strain of E. coli (Table
1) and allowed to grow for 18 h while shaking at 200rpm at 37oC. The overnight
cultures grew to approximately 109 CFU/ml, which were then diluted into 20% (w/v)
sucrose to 105 CFU/ml.
Colonization experiments:
The specifics of the streptomycin-treated mouse model used to compare the large
intestine colonizing abilities of E. coli strains in mice have been described previously
(34, 38, 54, 55, 56). Briefly, sets of three male CD-1 mice (5 to 8 weeks old) were
given drinking water containing streptomycin sulfate (5 g/L) for 24 h to eliminate
resident facultative bacteria (35). Following 18 h of starvation for food and water, the
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mice were fed 1 ml of 20% (w/v) sucrose containing 105 CFU of LB broth Lennox
(DIFCO) grown E. coli strains. After ingesting the bacterial suspension, both the food
(Teklad mouse and rat diet; Harlan Laboratories, Madison, WI) and streptomycinwater were returned to the mice, and 1 g of feces was collected after 5 h, 24 h, and on
odd-numbered days at the indicated times. Mice were housed individually in cages
without bedding and were placed in clean cages at 24 h intervals. Individual fecal
pellets were therefore no older than 24 h. Each fecal sample (1 gram) was
homogenized in 10 ml of 1% Bacto-Tryptone (DIFCO), diluted in the same medium,
and plated on Lactose MacConkey agar plates (DIFCO) with appropriate antibiotics.
When appropriate, 1 ml of a fecal homogenate (which were sampled after the feces
have settled) were centrifuged at 12,000 x g, resuspended in 100 µl of 1% BactoTryptone, and plated on a Latose MacConkey agar plate with appropriate antibiotics.
This procedure increases the sensitivity of the assay from 102 CFU/gram of feces to 10
CFU/gram of feces. To distinguish the various E. coli strains in feces, dilutions were
plated on lactose MacConkey agar containing streptomycin sulfate (100 µg/ml),
streptomycin sulfate (100 µg/ml) and nalidixic acid (50 µg/ml), streptomycin sulfate
(100 µg/ml) and rifampicin (50 µg/ml), or streptomycin sulfate (100 µg/ml) and
chloramphenicol (30 µg/ml). Streptomycin sulfate, chloramphenicol, rifampicin, and
nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). All plates were
incubated for 18 to 24 h at 37°C prior to counting (27). Mice were colonized with a
single representative strain of E. coli for 10 days prior to harvesting of cecum. The E.
coli strains used were (see Table 1): an O157:H7 pathogenic strain (EDL933), the
probiotic strain (Nissle 1917), a common laboratory strain (MG1655), and the two
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mutants of MG1655 selected by the mouse intestine (envZ

P41L

and flhDC). Also

included were a set of mice inoculated with a placebo of uninoculated 20% sucrose.
Fluorescent in situ Hybridization (FISH):
In order to study how different strains of E. coli associate locally with members
of the microbiota, we used Fluorescent In Situ Hybridization (FISH) on cross-sections
of cecum from streptomycin-treated mice colonized with a single strain of E. coli.
This was done in parallel with community analysis sequencing of bacterial populations
in mucus samples obtained from the cecum of similarly treated mice to better
understand how each strain of E. coli affects the development of the microbiome as a
whole. The mice included an uninoculated control set (blank 20% sucrose) and mice
inoculated with one of five representative strains of E. coli listed above. Each strain, as
well as the control, was fed simultaneously to 6 mice (105 CFU/mouse), which were
colonized for 10 days. On the tenth day, mice were killed via CO2 and their ceca were
harvested. Three of the mice from each set were used for FISH, while 3 of the mice
from each set were used for community analysis sequencing of mucus samples.
The cecum of a mouse designated for FISH was cut into 1-2 cm sections,
suspended in TissueTek® O.C.T compound (Sakura Finetek USA, Inc.) and snap
frozen in 2-methylbutane suspended in liquid nitrogen. Sections were then stored at 80oC until ready for sectioning. For sectioning, the Vibratome UltraPro 5000 cryostat
was used to cut sections at a thickness of 10um, which were adhered to poly-L-lysine
treated slides for visualization (LabScientific, Inc). Fixing of slides was done in 4%
Paraformaldehyde for 1 hour at room temperature, followed by a wash in PBS for 10
min. Slides were allowed to dry overnight prior to hybridization. Fluorescent probes
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were diluted in hybridization solution consisting of 10 ml of 1M Tris pH7.2, 18 ml of
5M NaCl, and 0.1 g of SDS in a total volume of 100 ml H20. All slides with sections
were treated using the FISH technique used by S. Macfarlane et al. (31), with
hybridization of E.coli specific (5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’) Cy-3
probe (red) and Eubacteria specific (5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’)
FitC probe (green) at concentrations of 5ng/µl and 25ng/µl, respectively.

These

probes were obtained from Integrated DNA Technologies (Coralville, IA). Briefly,
10µl of diluted probes in hybridization solution was pipetted to each slide, which were
then covered with a HybriSlip hybridization cover (Life Technologies, Carlsbad, CA)
and allowed to incubate in the dark for 2 h at 50°C. After 2 h the slides were dipped
in a wash buffer, which is simply hybridization solution without SDS added, and then
allowed to soak in the wash buffer for 20 min at 50°C. Slides were then rinsed with
distilled water and allowed to dry overnight before viewing. Sections on poly-Llysine treated slides were imaged using the Zeiss axioimager M2 imaging system with
the Zeiss LSM 700 confocal microscope and corresponding lasers (Carl Zeiss,
Oberkochen, Germany). The images acquired from the poly-L-lysine treated slides
were used to observe the biofilms with which the individual E. coli strains associate.
The poly-L-lysine treated slides were additionally treated with Vectashield (Vector
Laboratories, Inc.), an antibleaching agent which helps prolong fluorescence for
imaging. This involves placing a small drop of Vectashield on the hybridized slide
and then covering with a coverslip. Allowing 30 min at room temperature for the
Vectashield to dry made viewing easier, but was not absolutely necessary.
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Isolation of cecal mucus and DNA in cecal mucus:
For each mouse cecum being used in sampling of microbiota in the mucus, mucus
samples were scraped and collected into 5 ml of HEPES-Hanks buffer (pH7.2).
Microbial DNA was isolated using a MO BIO PowerSoilTM DNA Isolation Kit.
Sequencing:
PCRs to prepare samples for sequencing were done similarly for all mucus
scrapings. Primers were designed to match those used in a study of the human gut
microbiome which targeted the V4 variable region of the 16S rRNA (57). These
primers were obtained from Integrated DNA Technologies (Coralville, IA) and were
as follows: Forward (5’-TCG TCG GCA GCG TCA GAT GTG TAT AAG A-3’) and
Reverse (5’-GTC TCG TGG GCT CGG AGA TGT GTA TAA G-3’). Taq DNA
polymerase (New England BioLabs, Ipswich, MA.) was added to each PCR reaction,
which consisted of 25µl reactions: 2.5µl 10x Standard taq Reaction Buffer (New
England BioLabs Inc.), 0.5µl dNTP Solution Mix containing 10 mM of each dNTP
(New England BioLabs Inc.), 0.5µl of a 100µM solution of each primer, 0.5µl of the
aforementioned taq DNA polymerase (New England BioLabs), all added to 17.5µl of
DEPC treated nuclease free sterile water (Fisher Scientific). Each PCR reaction began
with an initial denaturation of 95°C for four min followed by a cycle of three steps
repeated 35 times. These were as follows: denature at 95°C for 30 s, annealing at
55°C for 20 s, and extension at 72°C for 30 s. The PCR ended with a final primer
extension at 72°C for 4 min. PCR was done using an Eppendorf® Mastercycler 5331
Gradient PCR Thermocycler (Westbury, NY). PCR products were checked via gel
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electrophoresis to be sure they contained one band of approximately 300 bp before
submission to the Rhode Island Genomics and Sequencing Center (RIGSC).
Once submitted to the RIGSC, after amplicon submission, a second round of PCR
(5 cycles) to attach Nextera (Illumina) indices and adapters was performed. Round 2
PCR reactions were cleaned with Agencourt Ampure XP (Beckman Coulter, Inc.),
visualized by agarose gel electrophoresis, and selected samples were analyzed using
the Agilent BioAnalyzer DNA1000 chip (Illumina). Qubit quantification was
performed on all samples prior to pooling, and KAPA quantification was performed
on the final pooled library prior to loading on the MiSeq flow cell. The samples were
then run on the Illumina MiSeq (Illumina RTA 1.17.28) hi-throughput sequencer.
Sequencing analysis:
Data output from the MiSeq comes as raw fastq files, which were then classified
using the published Mothur pipeline version 1.33 (49). Sequence processing was
aligned, cleaned of chimeric sequences, and classified using the MiSeq SOP (standard
operating procedure) made available by the Mothur authors (49).
Statistics
Means and standard deviations derived from the indicated samples were
compared by an unpaired Student's t test (P values).

A P value of >0.05 was

interpreted as indicating no significant difference, and a P value of <0.05 was
interpreted as indicating a significant difference.
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Results
Comparing communities
The quantification of the level of colonization by each strain was measured by
diluting and plating feces collected from colonized mice, as previously described (Fig.
1). Each E. coli strain was able to colonize mice at between 108 and 109 CFU/g feces.
As the control mice were fed a 20% sucrose placebo (without the addition of any E.
coli) strain, no E. coli colonies should have grown when plated on MacConkey agar
without any antibiotics added. As expected, no colonies were seen. FISH images
confirm that the strains exist in close proximity to other members of the gut
microbiota as a minimal member in larger biofilms (Fig 2-7). It can also be seen in
these images that the non-E. coli microbes are diverse in cell morphology.
Once the interaction between the E. coli strains and the members of the
microbiota had been confirmed, as well as the diversity of the microbial community,
the community structure of each individual strain was compared. This was done at the
phylum and family levels. As seen in (Fig. 8), all colonized mice showed similar
levels of Bacteroidetes, and Firmicutes.

For the E.coli Nissle 1917 and E. coli

EDL933 colonized mice, Deferribacteres seemed to be at lower levels than for mice
colonized with the other E. coli. Upon comparing the Nissle 1917 and EDL933
colonized mice to mice colonized with all of the other E. coli strains through an
unpaired students t test, it was shown that these low levels are only statistically
relevant when compared to the control and conventional mice (P < 0.0001). Mice that
were not colonized with any of the tested E. coli strains, i.e. the streptomycin treated
controls and untreated conventional mice, showed very little Proteobacteria at this
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level of classification. In contrast, the E. coli colonized mice showed much higher
levels of Proteobacteria, with the exception of the MG1655 envZ
mutants. The envZ

P41L

P41L

and flhDC

and flhDC mice showed lower levels of Proteobacteria when

compared to the other treatments inoculated by E. coli strains, but only the envZ

P41L

was statistically different in terms of Proteobacteria and only when compared to Nissle
1917 (P < 0.05). Even the Proteobacteria in the conventional and control mice were
only statistically different from Nissle 1917 (P < 0.05).
It appears that mice colonized with all the E. coli strains display similar diversity
at the family level (Fig. 9), with high levels of many of the same major members
across all mice. Statistically relevant differences between the population of s24-7, a
member of the Firmicutes phylum found in mice, is lower in Nissle 1917 samples
when compared to MG1655 envZP41L samples (P < 0.02), streptomycin treated
controls (P < 0.01), and the MG1655 flhDC mutant samples (P < 0.002).
Deferribacteraceae is considerably lower in Nissle 1917 and EDL933 colonized mice
when compared to control (P < 0.0001) and conventional mice (P < 0.0001). EDL933
colonized mice had the lowest level of Lachnospiraceae, which was only a statistically
significant difference when compared to MG1655 envZ

P41L

colonized mice (P <

0.05). Mice colonized with the MG1655 envZP41L and MG1655 flhDC mutants had
lower levels of Enterobacteriaceae when compared to the mice colonized with the
other E. coli strains, but only Nissle 1917 colonized mice were statistically higher and
only when compared to mice colonized with the MG1655 envZP41L mutant (P < 0.05).
The same was true for the control and conventional mice, with only Nissle 1917
colonized mice being statistically different in levels of Enterobacteriaceae (P < 0.05).
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Increasing the sample set for Nissle 1917 and MG1655
From the initial MiSeq sample set it was concluded that no significant difference
could be observed in the cecal mucus community structures of mice colonized with the
5 different E. coli strains. While certain differences did appear (i.e. s24-7 in Nissle
1917) this may have been due to the limited sample set (n=3), and so a second MiSeq
run was performed. Rather than testing only a few additional mice for each strain, 2
strains were chosen so as a larger data set could be gathered for each: Nissle 1917 and
MG1655. These strains were chosen as they are known to have different preferences
in terms of growth on sugars, and are able to co-colonize the gut without being in
direct competition (28).
An additional 11 mice colonized with MG1655 and 12 mice with Nissle 1917
were used. This would clarify if a larger sample size would allow visualization of
changes in the overall microbial community caused by colonization with specific
strains of E. coli. The relative abundance of major members of the gut microbiota was
compared at the phylum and family level in order to ascertain if colonization by
individual E. coli strains resulted in a percentage shifts of the major members, or if
different major members appeared.
As is seen in the (Fig. 10), Nissle 1917 colonized mice have a higher relative
abundance of Proteobacteria when compared to MG1655 (P < 0.02), and both Nissle
1917 and MG1655 fed mice have more Proteobacteria than the streptomycin treated
control mice (P < 0.0001 and P < 0.02, respectively). This difference is seen again at
the family level (Fig. 11) as represented by Enterobacteriaceae (a family in the
Proteobacteria

phylum)

with

Nissle

1917
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colonized

mice

having

more

Enterobacteriaceae than MG1655 colonized mice (P < 0.02), and both Nissle 1917 and
MG1655 colonized mice having more Enterobacteriaceae than the streptomycin
treated control mice (P < 0.0001 and P < 0.02, respectively). As the mice were treated
with streptomycin in order to clear natural Proteobacteria from the niches that
colonizing strains would inhabit, this difference in levels when compared to the
streptomycin treated controls would be expected. As for the other members of the
microbiota, there were no statistically significant differences between the individual E.
coli treatments.
Discussion
In the present study, we examined the community structure of mice colonized
with various strains of E. coli and their individual effects on the diversity of the cecal
mucus population. It has been shown that E. coli inhabits the gut as a minimal
member of mixed biofilms consisting of large anaerobe populations (27, Fig. 2-7), and
while certain major members of the population may be influenced by colonization
with specific strains of E. coli, more samples are likely necessary in order to elucidate
any statistically relevant shift in a population. This is shown in comparing the Nissle
1917 data, which in the first sample set (n=3) showed changes in levels of s24-7 and
Deferribacteriaceae, but increasing the sample size (n=15) debunks this finding as
Deferribacteriaceae and s24-7 are present at a higher relative abundance (Fig. 9 vs Fig.
11). It is important to note however that the depth of sequencing is important for
identifying key differences in these experiments, as the family level shows much
greater differences than the phylum level. Future work would likely need to focus on
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the family level, or if able to, the genus level of classification to elucidate key
differences caused by the colonizing E. coli strains.
Deferribacteres is a relatively recently described lineage, but one genus of
Deferribacteres, Mucispirillum, has been identified as existing in the mammalian gut
and being able to degrade mucin (20, 48). Lachnospiraceae is a member of the
Firmicutes that is able to produce butyric acid and has been previously linked to
obesity (36). Ruminococcaceae, another Firmicutes, has been previously shown to
exist in the gut, but is difficult to classify and is often a mistakenly identified
Lachnospiraceae (30). Paenibacillaceae is a Firmicutes with species that exist as plant
growth promoting rhizobacteria and may have been introduced through the feed given
to mice (4). The s24-7 family is a member of the Bacteroidetes that has been found to
inhabit the mouse gut, but little else has been described (17). Another bacteroidetes,
Porphyromonadaceae, has been previously shown to occasionally inhabit the gut, but
more often resides in oral cavities as a pathogen (39). Rikanellaceae is another
Bacteroidetes that has a recently reclassified member, Alistepes putredinis which was
previously classified as a Bacteroides and shows similarities with Bacteroides fragilis
and members of Porphyromonadaceae (47). Bacteroidaceae contains the Bacteroides
genus, which can use simple sugars when available, but use glycans as a main source
of energy (33).
Variation in the microbial communities amongst different hosts is common, and
even hosts from a common facility or litter may have differences amongst the
populations that inhabit their guts (29, 37, 45). This is illustrated by the fact that mice
used to test the same E. coli strain, and at the same time and under identical
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conditions, show differences in their community structures. As seen in (Fig. 9),
showing the relative abundance at the family level of an individual E. coli strain, the
standard deviation is considerable for many of the organisms present. Some families
aren’t even present in some of the mice, but are in high enough number to be
represented in another mouse.

As such, it is possible that any small effect in

colonization by an individual E. coli strain could be masked by this diversity amongst
hosts.
In addition to variation amongst hosts, the microbiota also consists of a vast
amount of members (between 500-1000 commensal strains [6, 7, 22, 41, 46, 51, 52]).
This could further mask any alteration in the community structure induced by
colonization with specific E. coli strains. If a specific organism were present as a
major member of the microbiota in one mouse, but only a minor member (or not
present at all) in another mouse, this would result in a large standard deviation for that
organism. So, even if a colonizing E. coli had an effect on this specific organism in
the population, it would look the same as if it were just an artifact of having different
hosts.

This is further complicated by the overall noise level of the gut, again

comprising of 500-1000 different organisms.
While the diversity between mice, as well as the large and complicated
community of the gut, may mask shifts in the populations caused by colonizing E. coli
it is still likely that the overall composition of the gut is not affected by the
colonization of a specific E. coli strain. However, this does not mean E. coli is not
important within the community and could still have a more localized effect on
members of the population.

Direct cell to cell interactions between E. coli and
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members of the microbiota that are within close proximity of one another may be
more directly affected by these individual strains, as opposed to an obvious shift in
large populations within the microbiome.

Redundancy of gene programs and

processes may allow the overall population to remain mostly unaffected by a minimal
member missing from the population (19), but a more subtle effect may occur in
localized niches. Further studies of direct cell to cell interactions may be necessary to
elucidate how an individual E. coli strain can affect the communities of the
mammalian gut, such as laser capture micro-dissections (LCM) (23). LCM coupled
with FISH techniques would allow the targeting of fluorescently labeled E. coli cells
within mixed biofilms to be captured and used for community analysis sequencing.
This would allow only the members in close association with the E. coli to be studied,
and remove much of the noise created by the overall communities of the gut.
In summary, the data presented here suggest that colonization with different
strains of E. coli does not affect the overall composition of the microbial communities
found within mouse cecal mucus. While increasing the sample size may give clarity
to some minute effects that occur due to colonization with these individual strains, it is
likely the overall noise level of the gut and the variation in the communities between
hosts will mask these effects. Moving forward, it could prove useful to directly study
the members that closely associate with the colonizing E. coli strains, through use of
laser capture micro-dissections, in order to avoid the clutter of the dense microbial
communities. Furthermore, focusing on deeper levels of classification could help
elucidate differences in these populations.
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Table 1 – Bacterial strains
E. coli strain

MG1655 StrR

Genotype/phenotype

Spontaneous streptomycin

Designation in

Source or

the text

reference

MG1655

3

15, 23

resistant mutant of MG1655
MG1655

546-bp deletion beginning

MG1655

StrR ΔflhD::cam

immediately downstream of

flhDC

IS1 in the regulatory region of
flhD and ending in flhD,
streptomycin and
chloramphenicol resistant
MG1655 envZ
P41L

StrR

P41L envZ missense mutant of

MG1655

MG1655 StrR

envZP41L

24

mutant
Nissle 1917 StrR

Spontaneous streptomycin

Nissle 1917

22, 41

EDL933

35

resistant mutant of Nissle 1917
EDL933 StrR RifR Spontaneous streptomycin
resistant mutant of EDL933
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Table 2 – Primers used
Primer designation

Sequence

of E.coli specific Cy-3 probe

5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’

(red) used for FISH
Eubacteria FitC probe (green)

5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’

used for FISH
16S V4 forward used for

5’-TCG TCG GCA GCG TCA GAT GTG TAT

community analysis sequencing

AAG A-3’

16S V4 reverse used for

5’-GTC TCG TGG GCT CGG AGA TGT GTA

community analysis sequencing

TAA G-3’
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Fig 1. Single strain colonizations of mice colonized with individual strains of E. coli.
This shows that the individual E. coli strains are able to colonize the mice at similar
levels.
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Fig 2. FISH image of a cross-section of cecum collected from mice colonized with
EDL933 for 10 days. Red bacterial cells represent E. coli labeled by the Cy3-probe,
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig 3. FISH image of a cross-section of cecum collected from mice colonized with
Nissle 1917 for 10 days. Red bacterial cells represent E. coli labeled by the Cy3probe, while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig 4. FISH image of a cross-section of cecum collected from mice colonized with
MG1655 for 10 days. Red bacterial cells represent E. coli labeled by the Cy3-probe,
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig 5. FISH image of a cross-section of cecum collected from mice colonized with
MG1655 flhDC for 10 days. Red bacterial cells represent E. coli labeled by the Cy3probe, while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig. 6. FISH image of a cross-section of cecum collected from mice colonized with
MG1655 envZP41L for 10 days. Red bacterial cells represent E. coli labeled by the
Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the FitCprobe.
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Fig. 7 FISH image of a cross-section of cecum collected from mice treated with
streptomycin but not colonized with any E. coli. Green bacterial cells represent all
Eubacteria labeled by the FitC-probe.
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Fig. 8 Bar plot showing relative abundance of major phyla in mucus samples by
treatment. In this set of experiments n=3. Error bars indicate standard error of the
mean. EDL933 and Nissle 1917 colonized mice show lower levels of Deferribacteres
when compared to the control and conventional mice (P < 0.0001). Only Nissle 1917
shows greater levels of Proteobacteria, and only when compared to MG1655 envZP41L
and the control and conventional mice (P < 0.05).
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Fig. 9 Bar plot showing relative abundance of major families in mucus samples by
treatment. In this set of experiments n=3. Error bars indicate standard error of the
mean. The level of s24-7 in the Nissle 1917 colonized mice was lower when
compared to the MG1655 mutants (envZP41L P < 0.02 and flhDC P <0.002) and the
streptomycin treated control (P < 0.01). Deferribacteraceae was lower in Nissle 1917
and EDL933 colonized mice when compared to the control and conventional mice
(P < 0.0001). EDL933 colonized mice had the lowest level of Lachnospiraceae, which
was only a statistically significant difference when compared to MG1655 envZP41L
colonized mice (P < 0.05). Enterobacteriaceae were lower in the envZP41L, control and
conventional mice when compared to Nissle 1917 mice (P < 0.05)
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Fig. 10 Bar plot showing relative abundance of major phyla in mucus samples by
treatment. For Nissle1917 samples n=15. For MG1655 samples n=14. For
streptomycin treated control samples n=15. Error bars indicate standard error of the
mean. The ony statistically significant differences were seen in the levels of
Proteobacteria, with Nissle 1917 fed mice having more than MG1655 fed mice (P <
0.02), and both Nissle 1917 and MG1655 fed mice having more Proteobacteria than
the streptomycin treated controls (P < 0.0001 and P < 0.02, respectively).
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Fig. 11 Bar plot showing relative abundance of major families in mucus samples by
treatment. For Nissle1917 samples n=15. For MG1655 samples n=14. For
streptomycin treated control samples n=15. Error bars indicate standard error of the
mean. Nissle 1917 colonized mice having more Enterobacteriaceae than MG1655
colonized mice (P < 0.02), and both Nissle 1917 and MG1655 colonized mice having
more Enterobacteriaceae than the streptomycin treated control mice (P < 0.0001 and
P < 0.02, respectively)
.
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MANUSCRIPT II
Developing an In Vitro Method for Studying the Interaction between E. coli and the
Intestinal Microbiota
Abstract
In order to better understand the interactions between E. coli and the members
of the intestinal microbiota, a novel in vitro method was developed. This method was
designed to be simple and inexpensive while providing an environment meant to
replicate the natural habitat of these organisms: the mammalian gut. The current study
examines the development of said in vitro model and its ability to mimic the mouse
gut in terms of diversity of organisms, as well as its usefulness in examining the
colonizing ability of competing E. coli strains.

It is shown that, while still in

development, this system is currently able to maintain diversity comparable to what is
seen in mice. While the abundance of these diverse organisms is not necessarily at the
levels seen in mice, the model is already an effective system for studying the microbial
community of the gut in a controlled environment. Furthermore, the system is able to
mimic certain colonization experiments of competing E. coli strains done in mice, and
with improvements to bolster the growth of the diverse population could be used as a
non-invasive method for studying gut microbes.
Introduction
While there are a diverse group of phyla represented within the mammalian
gut, the microbiota is dominated by two: Firmicutes and Bacteroidetes (15, 30, 55).
Facultative anaerobes, such as E. coli, are minimal yet important members of the gut
community, and it has been shown that E. coli inhabits mixed biofilms formed by
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anaerobes as a minority member (28). According to Freter’s nutrient-niche hypothesis
the community structure of the intestine is decided by nutrient availability, but also
assumes that all available nutrients within the intestine are perfectly mixed (17). We
previously proposed an adjustment to Freter’s nutrient-niche hypothesis, the
“Restaurant” hypothesis, which can be used to explain how the anaerobes in mixed
biofilms inhabited by E. coli provide them with mono- and di-saccharides locally,
rather than from a perfectly mixed pool available to all species (28). Furthermore, it
was hypothesized that differences in the outer surface between strains of E. coli may
have an effect on the binding affinity to the mixed biofilms and their consequent
growth (28).
Mucus in the gut exists in two forms, the loose layer and the firm layer (24).
The loose mucus layer is where most of the microbiota of the gut grow and form their
biofilms, while the firm mucus layer resides closer to the epithelial layer of the
intestines and prevents direct interaction of the commensal microbiota with host
epithelium (24). The mucus itself consists of a large mixture of molecules, including
but not limited to amino acids, large polysaccharides, mono- and disaccharides, and
mucin (3).

This mixture exists as a viscous liquid in which the microbes are

suspended and in which form biofilms. This environment is mostly anaerobic, with
minimal oxygen leaking from epithelial cells of the intestine (4, 20, 25, 29). Mucin is
a glycoprotein with large polysaccharide strands with which the anaerobe populations
of the gut can attach and form biofilms around (1). The biofilms formed by these
anaerobes can break down the large polysaccharides of the mucus, and parts of the
mucin, thus providing facultatives with usable mono- and disaccharides in bulk which
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would usually be limited (28, 43, 56). This gives facultatives, such as E. coli, a reason
for joining as minimal members in these anaerobe-formed biofilms, and perhaps even
promoting the growth of preferential anaerobes that provide specific mono- and
disaccharides (25). The facultatives that join these mixed biofilms likely provide the
anaerobes with protection from the minimal amount of oxygen that is released from
the epithelial tissue of the gut.
In vitro biofilm models allow the study of microbial communities as they form
complex biofilm structures in a contained and controllable environment (14, 21, 61).
Various biofilm models have been adapted to represent specific environments in order
to best mimic biofilm formation in vivo. These systems are diverse in setup and
function, ranging from flow displacement systems in which a constant flow of growth
medium in and waste products out (4, 21), to cell-culture-based models which allow
biofilms to develop on reconstituted human epithelia (50).
One system that is commonly used to study biofilms due to its simplicity is the
microtiter plate based model (8, 26, 46, 59). The biofilms using this model are grown
in microtiter well plates ranging from 6 to 96 well plates depending on necessity. This
allows for many environmentally identical biofilms to be studied at once, or individual
variables to be tested in each well (42). This system also allows for easy adjustment
over time in order to view the effects of variation in the media or additives on biofilm
development or maintenance (9, 23). However, a disadvantage of the microtiter plate
based models is that the system does not take into account the flow through of certain
environments such as the mouse gut (11, 47). This would mean that biofilms growing
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in the wells of the microtiter plate would eventually deplete available nutrients while
also accumulating waste (11).
Other systems take into account that the flow of new media into and old media
out of the system is important.

These flow models vary in design, with some

developed to maintain a perfect mixture of nutrients and other more simplistic systems
which allow the flow of the media to develop a natural gradient from one end of the
flow to the other (21). The continuous flow stirred tank reactor (CFSTR), a system
utilized by the CDC for biofilm studies, has an influx that matches the flow out of the
system with constant stirring where the biofilms grow (21). Planktonic cells can be
flushed out of the system by having the dilution rate of the media set faster than the
doubling time of the organisms in the system, leaving behind the attached organisms
in biofilms (21). The plug flow reactor (PFR) is similar in the control of media flow,
but does not have a container of media with constant stirring. Instead, plugs seeded
with biofilm forming organisms are locked in a row and media is allowed to flush past
them. Thus the media will have a higher concentration of substrates earlier in the flow
with a gradual decline in concentration further down the system (11, 21). While these
systems are designed to mimic the natural flow of available substrates in certain
environmental habitats, they also come with disadvantages. The continuous flow
stirred tank reactor setup tends to be labor intensive, with specialized equipment that
can be difficult to use or maintain. Both flow systems suffer from only being able to
test a single biofilm forming community per setup or experiment, as is a similar issue
with the media flowing into the system. The media required to maintain the system is
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also a substantial amount, as the constant flow requires fresh media to be prepared
based on the rate of flow (11).
In order to avoid some of the disadvantages of the previously described
systems, a simple in vitro system was developed with the specific intention of
mimicking bacterial growth in the mammalian gut. The developed gut system was
designed to be simplistic in nature, making it accessible to other researchers interested
in studying microbial communities in biofilms. The flow through of the natural gut
was also considered, and the system was developed with a dilution system meant to
mimic the diminishing and regrowth of the populations due to the constant flow of
mucus (47). Additionally, due to the simple dilution of growth into fresh media,
multiple variables could be tested on biofilms developed from a single source thus
allowing the observation of multiple conditions on identical biofilm communities.
The developed system is also small enough to be contained in a single microcentrifuge
tube, which allows for multiple samples or experiments to be run in tandem.
Materials and Methods
Bacterial strains:
Bacterial strains used in this study are listed in Table 1. The original E. coli K12 strain was obtained from a stool sample from a convalescing diphtheria patient in
Palo Alto, CA, in 1922 (Bachman BJ, 1996). The sequenced E. coli MG1655 strain
(CGSC 7740) was derived from the original K-12 strain, having only been cured of the
temperate bacteriophage lambda and the F plasmid by means of UV light and acridine
orange treatment (7). It has an IS1 element in the flhDC promoter (16). E. coli Nissle
1917 was originally isolated during World War I from a soldier who escaped a severe
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outbreak of diarrhea (53).

It has a beneficial effect on several types of intestinal

disorders, is well tolerated by humans, and has been marketed as a probiotic remedy
against intestinal disorders in several European countries since the 1920s (53). E. coli
EDL933 is the prototype strain of enterohemorrhagic E. coli (EHEC) O157:H7 (45).
The allelic exchange method described by Datsenko and Wanner (datsenko wanner
2001) was used to construct E. coli EDL933 StrR ΔppsA ΔpckA::cam (Table 1), with
deletions of 2,367 and 1,341 bp in the ppsA gene and the pckA gene, respectively.
Phosphoenolpyruvate carboxykinase converts oxaloacetate to phosphoenolpyruvate
and is encoded by the E. coli pckA gene (35). Phosphoenolpyruvate synthase is
encoded by the E. coli ppsA gene and converts pyruvate to phosphoenolpyruvate (41).
Since the conversion of TCA cycle intermediates to phosphoenolpyruvate is
completely blocked in a ppsA pckA double mutant, it is unable to grow on
gluconeogenic substrates “below” the step of phosphoenolpyruvate, but glycolytic
pathways are not affected (18).
Media and growth conditions:
LB broth-Lennox (DIFCO) was prepared as directed (20 g/L in water) and
sterilized. The approximate formula of LB broth Lennox (DIFCO) is listed as follows:
10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride. Bottles containing 10 ml
of LB broth Lennox (DIFCO) were inoculated with an individual strain of E. coli
(Table 1) and allowed to grow for 18 h while shaking at 200 rpm at 37°C. The
overnight cultures grew to approximately 109 CFU/ml, which were then diluted to 105
CFU/ml in 20% (w/v) sucrose when intended for mouse colonization, or HEPESHanks buffer when diluted for addition into the in vitro system.
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HEPES-Hanks buffer is 8 g/L NaCl, 0.4 g/L KCl, 0.185 g/L CaCl, 0.2 g/L MgSO4, 0.5
g/L Na2HPO4, 0.35 g/L KH2PO4, and 2.6 g/L HEPES in distilled water. This solution
was brought to pH 7.2 through addition of NaOH and filter sterilized (12). For the
experiments in which agarose was added, agarose was prepared separately at 0.6%
agarose (w/v) in distilled water and HEPES-Hanks buffer was prepared at twice the
above listed concentrations. The agarose was prepared fresh daily, and, as autoclaving
the agarose expels oxygen, provided further removal of oxygen from the samples. The
agarose and HEPES-Hanks were then mixed 1:1.
For the in vitro gut model, cecal mucus samples were harvested from the E.
coli colonized streptomycin-treated mice into 1 ml of HEPES-Hanks buffer (pH7.2)
including a reducing agent (3 mM Cleland’s reagent) to help prevent oxygen
poisoning of the anaerobe population within the sample, as well as 500 ug/ml porcine
intestinal mucin (Sigma). This sample was mixed thoroughly via pipetting, and then
incubated in a BD anaerobic GasPak™ system (Becton, Dickinson and Company)
overnight at 37oC. The following day, a 100µl sample of the overnight growth cecal
mucus bacterial culture was used to inoculate a fresh 1 ml sample of HEPES-Hanks
containing 2 mg/ml lyophilized mucus, 500µg/ml Porcine intestinal mucin (Sigma), 3
mM Cleland’s reagent, and 0.3% agarose. The freshly inoculated 1 ml sample was
labeled as Day 0 and incubated in a BD anaerobic GasPak™ system (Becton,
Dickinson and Company) overnight at 37°C. This procedure was repeated for 7 days,
using 100µl to inoculate a new 1 ml sample of fresh HEPES-Hanks containing 2
mg/ml lyophilized mucus, 500µg/ml Porcine intestinal mucin, 3 mM Cleland’s
reagent, and 0.3% agarose.

63

When using the in vitro method to compare colonization ability, slight
alterations were made to accommodate multiple strains. Initial sampling remained the
same, with pre-colonized mouse mucus being collected into 1 ml of HEPES-Hanks
buffer (pH7.2) including a reducing agent (3 mM Cleland’s reagent) to help prevent
oxygen poisoning of the anaerobe population within the sample, as well as 500µg/ml
porcine intestinal mucin (Sigma). This sample was mixed thoroughly via pipetting,
and then incubated in a BD anaerobic GasPak™ system (Becton, Dickinson and
Company) overnight at 37°C. On the same day as collection, strains to be used for
competitions were grown overnight in LB at 37°C while shaking. The following day,
a 10µl sample of the overnight culture was used to inoculate a fresh 1 ml sample of
HEPES-Hanks buffer containing 2 mg/ml lyophilized mucus, 500µg/ml Porcine
intestinal mucin (Sigma), 3mM Cleland’s reagent, and 0.3% agarose. At this point,
10µl of the strains to be used for competition were diluted in at a final concentration of
102-103 CFU, having been diluted in HEPES-Hanks buffer from the overnight culture.
10µl of the freshly made sample was used for serial dilutions and plating on Lactose
MacConkey agar (DIFCO) containing antibiotics as previously described (also
described below in ‘Colonization Experiments’) to obtain counts of, and differentiate
between strains of E. coli within the population.
Preparation of lyophilized cecal mucus
Cecal mucus was collected via scraping from 15 mice into 30 ml of HEPESHanks buffer. The mucus collections were then centrifuged using a Sorvall™ RC6
Plus (Thermo Scientific) at an rcf of 10,000 x g for 10 mins. The supernatant was
collected without disturbing the pellet, at which point the collected supernatant was
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frozen at -80oC and the pellet was discarded. Afterwards, the frozen supernatant was
placed in a FreeZone Plus 12 Liter Cascade Console Freeze Dry System
(LABCONCO) for 48 h to remove all liquid from the collected mucus.

The

lyophilized mucus was then stored at -20°C until needed. This was done for each in
vitro experiment.
Colonization experiments:
The specifics of the streptomycin-treated mouse model used to compare the
large intestine colonizing abilities of E. coli strains in mice have been described
previously (34, 39, 56, 58, 60). Briefly, sets of three male CD-1 mice (5 to 8 weeks
old) were given drinking water containing streptomycin sulfate (5 g/L) for 24 h to
eliminate resident facultative bacteria (37). Following 18 h of starvation for food and
water, the mice were fed 1 ml of 20% (w/v) sucrose containing 105 CFU, or 1010, CFU
of LB broth Lennox (DIFCO) grown E. coli strains. After ingesting the bacterial
suspension, both the food (Teklad mouse and rat diet; Harlan Laboratories, Madison,
WI) and streptomycin-water were returned to the mice, and 1 g of feces was collected
after 5 h, 24 h, and on odd-numbered days at the indicated times. Mice were housed
individually in cages without bedding and were placed in clean cages at 24-h intervals.
Individual fecal pellets were therefore no older than 24 h. Each fecal sample (1 gram)
was homogenized in 10 ml of 1% Bacto-Tryptone (DIFCO), diluted in the same
medium, and plated on Lactose MacConkey agar plates (DIFCO) with appropriate
antibiotics. When appropriate, 1 ml of a fecal homogenate (which were sampled after
the feces settled) were centrifuged at 12,000 x g, resuspended in 100µl of 1% BactoTryptone, and plated on a Lactose MacConkey agar plate (DIFCO) with appropriate
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antibiotics. This procedure increases the sensitivity of the assay from 102 CFU/gram of
feces to 10 CFU/gram of feces. To distinguish the various E. coli strains in feces,
dilutions were plated on Lactose MacConkey agar (DIFCO) containing streptomycin
sulfate (100 µg/ml), streptomycin sulfate (100 µg/ml) and nalidixic acid (50 µg/ml),
streptomycin sulfate (100 µg/ml) and rifampicin (50 µg/ml), or streptomycin sulfate
(100 µg/ml) and chloramphenicol (30 µg/ml). Streptomycin sulfate, chloramphenicol,
rifampicin, and nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO).
All plates were incubated for 18 to 24 h at 37°C prior to counting (28).
Fluorescent in situ Hybridization (FISH):
In order to observe how E. coli associate locally with members of the
microbiota in vivo, we used Fluorescent In Situ Hybridization (FISH) on crosssections of cecum from streptomycin-treated mice colonized with a single strain of E.
coli. These observations were used to compare the similar interactions in the in vitro
system. This was done in parallel with community analysis sequencing of bacterial
populations in mucus samples obtained from the cecum of similarly treated mice in
order to compare the diversity of the in vivo and in vitro models. The mice included
an uninoculated control set (blank 20% sucrose) and mice inoculated with E. coli
Nissle 1917. Samples of conventional and Nissle 1917 inoculated mice were done
simultaneously for 6 mice, which were colonized for 10 days. On the tenth day, mice
were killed via CO2 and their ceca were harvested. Three of the mice from each set
were used for FISH, while 3 of the mice from each set were used for community
analysis sequencing of mucus samples. For in vitro samples, 10µl of the sample was
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used to prepare slides for FISH and the remaining sample was used for community
analysis sequencing.
The cecum of a mouse designated for FISH was cut into 1-2 cm sections,
suspended in TissueTek® O.C.T compound (Sakura Finetek USA, Inc.) and snap
frozen in 2-methylbutane suspended in liquid nitrogen. Sections were then stored at
-80°C until ready for sectioning.

For sectioning, the Vibratome UltraPro 5000

cryostat was used to cut sections at a thickness of 10µm, which were adhered to polyL-lysine treated slides for visualization (LabScientific, Inc). Fixing of slides was done
in 4% Paraformaldehyde for 1 hour at room temperature, followed by a wash in PBS
for 10 min. Slides were allowed to dry overnight prior to hybridization. Fluorescent
probes were diluted in hybridization solution consisting of 10ml of 1M Tris pH7.2,
18ml of 5M NaCl, and 0.1g of SDS in a total volume of 100ml H20. All slides with
sections were treated using the FISH technique used by S. Macfarlane et al. (32), with
hybridization of E.coli specific (5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’) Cy-3
probe (red) and Eubacteria specific (5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’)
FitC probe (green) at concentrations of 5ng/µl and 25ng/µl, respectively.

These

probes were obtained from Integrated DNA Technologies (Coralville, IA). Briefly,
10µl of diluted probes in hybridization solution was pipetted to each slide, which were
then covered with a HybriSlip hybridization cover (Life Technologies, Carlsbad, CA)
and allowed to incubate in the dark for 2 h at 50°C. After 2 h the slides were dipped
in a wash buffer, which is simply hybridization solution without SDS added, and then
allowed to soak in the wash buffer for 20 min at 50°C. Slides were then rinsed with
distilled water and allowed to dry overnight before viewing. Sections on poly-L-
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lysine treated slides were imaged using the Zeiss axioimager M2 imaging system with
the Zeiss LSM 700 confocal microscope and corresponding lasers (Carl Zeiss,
Oberkochen, Germany). The poly-L-lysine treated slides were additionally treated
with Vectashield (Vector Laboratories, Inc.), an antibleaching agent which helps
prolong fluorescence for imaging. This involves placing a small drop of Vectashield
on the hybridized slide and then covering with a coverslip. Allowing 30 mins at room
temperature for the Vectashield to dry made viewing easier, but was not absolutely
necessary.
Isolation of cecal mucus and DNA in cecal mucus and in in vitro samples:
For each mouse cecum being used in sampling of microbiota in the mucus,
mucus samples were scraped and collected into 5 ml of HEPES-Hanks buffer (pH7.2).
The in vitro samples were collected directly from overnight growth into DNA
isolation kits. Microbial DNA was isolated using a MO BIO PowerSoilTM DNA
Isolation Kit.
Sequencing:
PCR reactions to prepare samples for sequencing were performed similarly for
all mucus scrapings and in vitro samples. Primers were designed to match those used
in a study of the human gut microbiome which targeted the V4 variable region of the
16S rRNA (62). These primers were obtained from Integrated DNA Technologies
(Coralville, IA) and were as follows: Forward (5’-TCG TCG GCA GCG TCA GAT
GTG TAT AAG A-3’) and Reverse (5’-GTC TCG TGG GCT CGG AGA TGT GTA
TAA G-3’). Taq DNA polymerase (New England BioLabs, Ipswich, MA.) was added
to each PCR reaction, which consisted of 25µl reactions: 2.5µl 10x Standard taq
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Reaction Buffer (New England BioLabs Inc.), 0.5µl dNTP Solution Mix containing 10
mM of each dNTP (New England BioLabs Inc.), 0.5µl of a 100µM solution of each
primer, 0.5µl of the aforementioned taq DNA polymerase (New England BioLabs), all
added to 17.5µl of DEPC treated nuclease free sterile water (Fisher Scientific). Each
PCR reaction began with an initial denaturation of 95°C for four min followed by a
cycle of three steps repeated 35 times. These were as follows: denature at 95°C for 30
s, annealing at 55°C for 20 s, and extension at 72°C for 30 s. Each PCR reaction
ended with a final primer extension at 72°C for 4 min. PCR was done using an
Eppendorf® Mastercycler 5331 Gradient PCR Thermocycler (Westbury, NY). PCR
products were checked via gel electrophoresis to be sure they contained one band of
approximately 300 bp before submission to the Rhode Island Genomics and
Sequencing Center (RIGSC).
Once submitted to the RIGSC, after amplicon submission, a second round of
PCR (5 cycles) to attach Nextera (Illumina) indices and adapters was performed.
Round 2 PCR reactions were cleaned with Agencourt Ampure XP (Beckman Coulter,
Inc.), visualized by agarose gel electrophoresis, and selected samples were analyzed
using the Agilent BioAnalyzer DNA1000 chip (Illumina). Qubit quantification was
performed on all samples prior to pooling, and KAPA quantification was performed
on the final pooled library prior to loading on the MiSeq flow cell. The samples were
then run on the Illumina MiSeq (Illumina RTA 1.17.28) hi-throughput sequencer.
Sequencing analysis:
Data output from the MiSeq comes as raw fastq files, which were then
classified using the published Mothur pipeline version 1.33 (52). Sequence processing
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was aligned, cleaned of chimeric sequences, and classified using the MiSeq SOP
(standard operating procedure) made available by the Mothur authors (52).
The in vitro system observations:
In order to visualize early microbial communities and how E. coli affects the
growth of the anaerobes within mixed biofilms during early development in the in
vitro system, FISH images were taken daily. 10µl of the overnight growth of the in
vitro system was used to prepare and observe a slide using previously described FISH
techniques.

Another 10µl was used for serial dilutions and plating on Lactose

MacConkey agar (DIFCO) containing antibiotics as previously described to obtain
counts of E. coli within the population.
Generating crude rarefaction curves
Crude rarefaction curves were generated using the classifications generated
through the Mothur pipeline (52) to group the sequences at the family level. This is
done by randomly sampling from the families, with consideration that each family
represents a unique member of the microbiota. A higher abundance of a specific
family increases the likelihood that this specific family will be sampled, thus
experiments with a majority of its members being represented by one or two families
will have a lower measure of diversity when compared to those with abundance spread
across more families. Actually having more unique families within an experiment will
also increase the measure of diversity. Sampling was done from 100 picks to 5000
picks, with intervals of 100, and each was repeated 100 times.
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Statistics
Means and standard deviations derived from the indicated samples were
compared by an unpaired Student's t test (P values). A P value of > 0.05 was
interpreted as indicating no significant difference, and a P value of < 0.05 was
interpreted as indicating a significant difference.

Results
Initial experiments to develop the in vitro system
The in vitro model of the gut was designed to mimic the loose mucus layer
found in the cecum of mice. To do this, the anaerobe populations needed to be
protected from excessive oxygen stress. This was accomplished by adding 3mM of
Cleland’s reagent, a reducing agent that sequesters oxygen, thus providing the
anaerobes with an oxygen free environment. In addition to this, 100µg/ml of mucin
was added to provide nutrients and an attachment site for the anaerobes to begin
forming biofilms. 2 mg/ml of mucus was also added to provide an additional source
of nutrients. All of these additives were dissolved into HEPES-Hanks buffer at pH
7.2, a buffer used for gut microbes that lacks any source of carbon or nitrogen (12). In
order to mimic the constant flow through and growth present in the gut, samples were
diluted into fresh mixtures containing Cleland’s, mucin, and mucus in HEPES-Hanks
buffer every 24 hours. It was shown that while the microbial populations collected
from the mouse gut could survive 1-2 days in this in vitro system (Fig. 1), a majority
of the anaerobic population was lost after 3 days (Fig. 2). In addition to losing
diversity and quantity of anaerobes, E. coli that was spiked into the system grew to be
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a majority of the sample (Fig. 2).

This contrasts what is seen in the natural

environment inside mice, where E. coli is a minimal member of vast microbial
biofilms (28).
Increasing mucin concentration to 500 µg/ml improves diversity beyond day 3
In an attempt to improve survivability of the anaerobe population, the mucin
concentration was increased to 500 µg/ml. The increase of mucin concentration not
only provided anaerobes with more binding sites for initiating biofilm formation and
food in the form of large polysaccharide chains, but also visibly increased the
viscosity of the solution. This increase in viscosity better mimicked the loose mucus
of the gut, possibly providing the microbe populations with an environment more akin
to what they prefer in their natural hosts. This 5-fold increase in mucin concentration
improved the in vitro system to the point where the anaerobe populations survived
well up to day 5. However, day 6 showed a steep loss of anaerobe populations and
again showed the E. coli taking over as the majority (Fig. 3).
Adding agarose increases viscosity of solution and anaerobe survival
While increasing the concentration of mucin in the system increased the
viscosity of the samples, they were still not quite as viscous as what is seen in the
loose layer of mucus. To increase the viscosity further, 0.3% agarose was added to the
solution. The specific amount of agarose to add was found to be the highest amount
that could be added and still be feasibly pipetted. This addition of agarose created an
environment that appeared to be similar in viscosity to mucus of the loose layer. As
such, biofilms formed by the microbes of the gut would no longer settle to the bottom
of the sample and could instead create networks throughout. The agarose may also
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have provided additional protection from oxygen, as it would be more difficult for the
oxygen to penetrate deep into the samples.

The addition of agarose showed

considerable improvement in the survivability of the anaerobe populations, with the
populations remaining robust and diverse through day 6 (Fig. 4).
Precolonizing the mouse with E.coli prior to mucus collection further improves
anaerobe survival in the in vitro system
In all previous experiments, E. coli was added after mucus samples were
collected into the in vitro system.

While the addition of agarose improved the

longevity of anaerobe populations, E. coli growth was still higher than that seen in the
mouse beyond day 6. The anaerobe populations also seemed to decline, albeit slowly,
as time progressed beyond day 6. It was possible that this was due to E. coli being
added to the cecal mucus preparations in vitro and not in vivo. In order to alleviate
this, E. coli was fed to mice and allowed to colonize for 3 days prior to collection of
the microbiota. This allowed the E. coli to form their relationships with their preferred
anaerobes in the natural environment of these organisms.

When E. coli was

precolonized in mice prior to collection of the microbiota, anaerobe populations
remained in high number and diversity through day 7 and beyond (Fig. 5, 6).
Additionally, E. coli populations no longer grew to take over as majority members of
the sample (Fig. 5, 6).
Testing the necessity of the individual additives in the in vitro system
Once the anaerobe populations were surviving beyond day 7 and the E. coli
population was kept in check, it was necessary to test if all of the components within
the in vitro system were actually involved in maintaining said populations.
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To

accomplish this, growth in vitro was tested after the removal of a single component in
parallel with a sample containing every component. In samples sans Cleland’s reagent
or mucin the anaerobe populations were lost within 1-2 days and the E. coli population
grew to 108 CFU/ml (Fig. 7). Without mucus, both the anaerobes and E. coli were lost
(Fig. 8).
Can the concentration of mucus be adjusted in order to control the E. coli
population?
With the in vitro system becoming more similar to the mouse gut, an attempt to
control the E. coli population by adjusting the mucus concentration was tested.
Several concentrations were tested: no mucus, 0.2mg/ml mucus, and 2mg/ml mucus
(Fig. 8). While 10-fold less mucus (0.2mg/ml) showed no noticeable decline in the E.
coli population, the anaerobe population suffered considerably (Fig. 8). Even without
any added mucus the E. coli was able to maintain itself to some degree (1x107
CFU/ml) (Fig. 8), likely due to the mucin not being completely purified of mono- and
disaccharides.
Comparing diversity of in vivo and in vitro samples
To better compare the diversity of the in vitro system to what is seen in vivo,
samples were taken from the in vitro Nissle 1917 pre-fed experiments after 7 days and
used for community analysis sequencing. The pre-fed experiments were those in
which mice were first colonized with Nissle 1917 for 3 days prior to collecting into the
in vitro system. Community analysis of the in vitro samples at day 7 shows some
diversity amongst major members of the population at the family level (Fig. 9). A
stacked bar plot was generated to compare the diversity in individual experiments
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(Fig. 10). The in vivo and in vitro samples of Nissle 1917 have similar diversity with
representation from the same set of families except Deferribacteraceae. However, the
in vitro samples do have Deferribacteraceae at low levels, and are statistically similar
when compared to the in vivo samples in terms of Deferribacteraceae using the
student’s t-test (P > 0.05). At the phylum level, Bacteroidetes and Firmicutes are
comparable to what is seen in vivo, but Deferribacteres has little representation (Fig.
11, Fig. 12). Again, the difference in levels of Deferribacteres are not statistically
significant between the in vivo and in vitro samples (P > 0.05).
In order to see if the overall population was similar in terms of overall
diversity between the in vitro and the in vivo methods, a crude rarefaction curve was
generated for select samples of each experimental type. When comparing 3 samples
of E. coli Nissle 1917 in vitro to 3 samples of E. coli Nissle 1917 in vivo at the family
level, both experimental types have similar levels of diversity (Fig. 13).

This

similarity in diversity when comparing the entire population, as opposed to the most
abundant organisms within the population, suggests that the in vitro system is truly
near the mouse gut in terms of community structure.
Using conventional mice for the in vitro system
While streptomycin treatment is important for testing the colonization ability
of E. coli, cultivating the unaltered gut microbiome in vitro may be of more interest.
As such, mice that were not treated with streptomycin (thus still containing the natural
Proteobacteria) were killed and their mucus was collected for the in vitro system.
Slides were prepared with FISH and images were taken for 7 days. Through day 7, in
vitro samples showed diversity in cell morphology and E. coli labeled cells were seen
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within mixed biofilms (Fig. 14). Community analysis of the samples at day 7 in vitro
showed diversity amongst major members of the population at the family level (Fig.
15, Fig. 16), with members present within the in vitro system being comparable to
those seen in in vivo samples, although differences between the in vitro and in vivo
samples were seen in the Bacteroideaceae (P < 0.0001), Deferribacteraceae (P <
0.001), and Lachnospiraceae (P < 0.001). At the phylum level, Bacteroidetes were
more abundant relative to Firmicutes in the conventional in vitro samples compared to
what was seen in the in vivo samples, and Deferribacteres had little representation in
vitro (Fig. 17, Fig. 18). The differences seen between each phylum; Bacteroidetes,
Deferribacteres, and Firmicutes, are statistically significant (P < 0.001 for each). The
loss of Firmicutes can be traced to the Lachnospiraceae family, which has a high
abundance in the samples taken directly from mice but is considerably lower in the in
vitro samples (P < 0.01) (Fig. 15).
In order to see if the overall population was similar in terms of overall
diversity between the in vitro and the in vivo methods, a crude rarefaction curve was
generated for select samples of each experimental type.

When comparing 3

conventional in vitro samples to 3 conventional in vivo samples at the family level,
both experimental types have similar levels of diversity (Fig. 19). It is also apparent
that conventional samples are more diverse than Nissle 1917 samples, likely due to the
treatment of streptomycin prior to colonization. This similarity in diversity when
comparing the entire population, as opposed to the most abundant organisms within
the population, suggests that the in vitro system is truly near the mouse gut in terms of
community structure.
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Testing the ability of pre-colonized strains to prevent later colonization with the
same strain
When mice are pre-colonized with an E. coli strain, they are resistant to
subsequent intestinal colonization by the same strain (2, 27). This is likely because
the niches usually taken by these E. coli strains are already filled by the preexisting
population. To test if this is true in the in vitro system, mice were pre-colonized with
either Nissle 1917 or MG1655 and then collected into the in vitro system after 3 days
of colonization. After 7 days in the in vitro system, the identical strain was spiked in
at 103 CFU/ml (Nissle 1917 for Nissle 1917, and MG1655 for MG1655).

As

expected, pre-colonized Nissle 1917 prevented the late fed Nissle 1917 from growing
up (Fig. 20), and pre-colonized MG1655 prevented late fed MG1655 from growing to
higher numbers (Fig. 21).
Testing the colonization ability of Nissle vs MG1655 in vitro
Once the populations were maintained, it was important to test if the in vitro
system was truly mimicking the mouse gut. To do this, competition between E. coli
strains that had been previously tested in mouse colonization experiments were used.
Mice were initially inoculated with the Nissle 1917 for 3 days, and then the microbiota
was collected into the in vitro system. The populations were sustained for 7 days, and
then MG1655 was spiked in at 105 CFU/ml. In vivo, mice fed Nissle 1917 early and
MG1655 late show no direct competition between the strains, i.e. as Nissle 1917 and
MG1655 can outcompete one another on one or more sugars, they are able to cocolonize in vivo without issue (17). In vitro, MG1655 was not able to co-colonize

77

with Nissle 1917, and dropped below detectable numbers 4 days after being spiked in
(Fig. 22). However, the reverse showed more promising results. When MG1655 is
fed early and Nissle 1917 fed late in mice, they are able to co-colonize as they are not
in direct competition (17). This proved to be true in vitro as well, when MG1655 was
fed early to mice before collection and Nissle 1917 was spiked in at day 7 in vitro
(Fig. 23).
In the presence of E. coli Nissle 1917, E. coli EDL933 uses gluconeogenesis to
colonize the in vitro system as it does in vivo.
In vivo, EDL933 uses gluconeogenesis when co-colonized with Nissle 1917 in
order to maintain itself within the gut (51). This is known because when a mouse is
pre-colonized with Nissle 1917 for 10 days and then fed 105 CFU each of EDL933
wildtype and EDL933 ppsA pckA (a mutant unable to grow on gluconeogenic nurients
“below” phosphoenolpyruvate) the mutant EDL933 is unable to compete and falls to
undetectable numbers (51).
In order to test if the in vitro system mimicked the mouse gut, this experiment
was repeated in vitro. To do this, Nissle 1917 was pre-colonized in mice at 105
CFU/ml for 10 days, and EDL933 and EDL933 ppsA- pckA- were spiked into the in
vitro system at 103 CFU/ml one day after collection. EDL933 wildtype and the
EDL933 ppsA- pckA- mutant were spiked at 103 CFU/ml because they were spiked
into a fresh dilution of the microbiota, which would leave Nissle 1917 at
approximately 107 CFU/ml. This would give a difference of 104 CFU/ml, the same
difference when fed late to mice. When the in vitro experiment was performed with
Nissle 1917 pre-colonized for 10 days after which the wildtype EDL933 and the
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EDL933 ppsA- pckA- mutant were spiked into the in vitro system one day after
collection, it mimicked the mouse experiments (Fig. 24), i.e Nissle 1917 colonized at
approximately 108 CFU/ml, EDL933 wildtype maintained itself at approximately 104
CFU/ml, and EDL933 ppsA- pckA- fell below detectable numbers by day 4.
EDL933 vs. EDL933 ppsA-pckAIn mice, EDL933 and EDL933 ppsA-pckA- can co-colonize equally well in the
absence of Nissle 1917 (51), suggesting that in the absence of Nissle 1917, EDL933 is
not forced to use gluconeogenic substrates in order to compete and thus the nongluconeogenic mutant is not at a disadvantage. This was tested in the in vitro system
by collecting mucus from streptomycin treated mice for collection into the in vitro
solution, and EDL933 and EDL933 ppsA- pckA- were spiked into the in vitro system
at 103 CFU/ml 1 day after collection. Initially, both strains were able to grow to
similar counts at approximately 107 CFU/ml, but eventually the EDL933 ppsA- pckAmutant began to drop. Unlike in mice, the EDL933 and EDL933 ppsA- pckA- were
unable to co-colonize, with the EDL933 ppsA- pckA- mutant falling below detectable
numbers after 10 days in vitro (Fig. 25).
Discussion
In this study, an in vitro method for cultivating the microbiota of the
mammalian gut was developed. This method will allow us to study the relationship
between E. coli and the rest of the gut microbiota with more control and accessibility
than in in vivo models, such as the streptomycin treated mouse model. While other in
vitro methods have been developed to study biofilms from various environments, this
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novel method was designed specifically for the gut microbiota, and it was kept as
simple and user friendly as possible.
During the development of this in vitro method, samples of growth from the in
vitro system were submitted for community analysis sequencing of the microbial
community. These samples were taken from day 7 in vitro samples of Nissle 1917
and another set of samples in which the cecal mucus of untreated mice (not colonized
with E. coli or treated with streptomycin) were collected into the in vitro system
(labeled “conventional”). The in vitro samples were compared to in vivo samples
prepared similarly, by either pre-colonizing mice with Nissle 1917 for 10 days, at
which point the mice were killed and mucus was collected, or in vivo samples that
were collected from untreated (conventional) mice.
By comparing the Nissle 1917 in vivo and in vitro samples at the phylum level
it can be seen that a similar spread of major members of the population can survive
within the in vitro system, but a loss in the relative abundance of certain organisms
occurs (Fig. 11, Fig. 12). While the abundance of Firmicutes and Bacteroidetes are
comparable between the in vivo and in vitro methods, Deferribacteres seems to have
trouble surviving the in vitro system. Deferribacteres is not completely lost, as it is
present at lower levels in these samples but still exists.
At the family level, both Nissle 1917 in vitro and in vivo samples have
representatives from the same families (Fig. 9, Fig. 10). Deferribacteriaceae has
relatively low levels of representation in the in vitro system, but again is still present.
However, the loss of relative abundance of these major members does not coincide
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with an overall loss of diversity as shown by (Fig. 13) with both in vivo and in vitro
samples of Nissle 1917 showing similar levels of diversity.
When comparing phyla of the conventional samples, in vitro to in vivo, a
similar loss of Deferribacteres is seen (Fig. 17). Again, this loss is not a complete
clearing of Deferribacteres but rather a loss in the relative abundance of the organism.
The diversity of major members at the family level is much higher in the conventional
samples (in vitro and in vivo), with a larger spread across various families than that
seen in the Nissle 1917 samples (Fig. 15). Furthermore, the diversity of the individual
conventional samples was much more robust than the Nissle 1917 samples both in
vivo and in vitro, showing higher diversity in a crude rarefaction curve (Fig. 19). This
shows that the conventional samples in vitro are truly diverse, and also mimic the in
vivo conventional samples in level of diversity.
Deferribacteres is a relatively recently described lineage, but one genus of
Deferribacteres, Mucispirillum, has been identified as existing in the mammalian gut
and being able to degrade mucin (22, 49). Interestingly, Deferribacteres were lower in
many of the in vitro samples, possibly due to the low concentration of mucin which
Mucispirillum utilizes for growth. Lachnospiraceae is a member of the Firmicutes that
is able to produce butyric acid and has been previously linked to obesity (36).
Ruminococcaceae, another Firmicutes, has been previously shown to exist in the gut,
but is difficult to classify and is often a mistakenly identified Lachnospiraceae (31).
Paenibacillaceae is a Firmicutes with species that exist as plant growth promoting
rhizobacteria and may have been introduced through the feed given to mice (5). The
s24-7 family is a member of the Bacteroidetes that has been found to inhabit the
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mouse gut, but little else has been described (19).

Another bacteroidetes,

Porphyromonadaceae, has been previously shown to occasionally inhabit the gut, but
more often resides in oral cavities as a pathogen (40). Rikanellaceae is another
Bacteroidetes that has a recently reclassified member, Alistepes putredinis which was
previously classified as a Bacteroides and shows similarities with Bacteroides fragilis
and members of Porphyromonadaceae (48). Bacteroidaceae contains the Bacteroides
genus, which can use simple sugars when available, but use glycans as a main source
of energy (33).
In order to show that the novel in vitro system could mimic the mouse in terms
of colonization ability, a series of tests were done using the new in vitro system in
parallel to those done with mice. Early attempts at comparing in vivo colonization
experiments to those done in vitro proved that the system was not quite identical to the
mouse, but similarities were present. When mice are pre-colonized with an E. coli
strain, they are resistant to subsequent intestinal colonization by the same strain (2,
27). This was tested in the in vitro method with Nissle 1917 and MG1655, and this
colonization resistance was also seen in the in vitro system (Fig. 20, Fig. 21).
However, it was previously shown that colonization by a different strain would be
possible, so long as the pre-fed strain and the new strain were not in direct competition
for sugars (17). This was again tested in vitro using Nissle 1917 and MG1655. When
MG1655 was pre-fed and Nissle 1917 was added late, Nissle 1917 was able to grow
up with MG1655 as is seen in mice (Fig. 23). In contrast, when Nissle 1917 was prefed and MG1655 was added late, MG1655 was unable to grow up against Nissle 1917
and was eventually washed out of the system (Fig. 22). This may be due to the system
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developing early with Nissle 1917, thus promoting an anaerobe population that is
more preferential for the growth of Nissle 1917. If said population only produced
mono- and disaccharides that resulted in Nissle 1917 and MG1655 growing in direct
competition, with Nissle 1917 being able to grow faster on the supplied sugars,
MG1655 would be unable to colonize and would eventually fall below detectable
numbers. It is also possible that Nissle 1917 may use up all the nutrients in vitro, but
not in vivo, as nutrients are likely more limited in the in vitro system. Another
possibility is that the flow through of the gut is important for either directly keeping
the population of Nissle 1917 in check, or for keeping certain key anaerobes in check
that give Nissle 1917 a competitive edge over MG1655. This same effect could be
carried out by the innate immune system of the gut. Considering that when MG1655
was pre-fed and Nissle 1917 was added late both were able to grow and colonize
equally well, it is unlikely to be due to population control via flow or the innate
immune system. It is important to note that as these experiments were done early in
the development of the system, mice were only pre-colonized for 3 days prior to being
moved into the in vitro system, and then allowed a further 7 days for the pre-colonized
E. coli strain to settle before spiking in the competing strain. Perhaps allowing the
pre-colonized strain to remain in mice for the full 10 days prior to collection into the
in vitro system could improve these colonizations.
Another competition chosen was Nissle 1917 fed early against EDL 933
wildtype and EDL933 ppsA- pckA-.

EDL933 is an enterohemorrhagic E. coli

(EHEC), and the mutant EDL933 ppsA- pckA- is unable to utilize gluconeogenic
substrates (51). In mice, Nissle 1917 keeps EDL933 wildtype from colonizing higher
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than 106 CFU/gfeces and EDL933 ppsA- pckA- is unable to colonize, falling below
detectable numbers after only a few days (51). In the mice, late fed strains are fed 10
days after the pre-colonizing strain. To better mimic this, an experiment was done in
which the pre-colonizing strain was allowed to remain in the mice for 10 days prior to
collecting into the in vitro system. In this experiment, Nissle 1917 was fed to the mice
while the EDL 933 and EDL 933 ppsA- pckA- strains were added later to the in vitro
system. This experiment mimicked the mouse experiment, showing that the in vitro
method was beginning to more mimic the mouse (Fig. 24).
A final experiment was done to see how closely the in vitro system mimicked
the mouse gut in terms of colonization ability. In the absence of Nissle 1917, EDL933
and EDL933 ppsA- pckA- are able to colonize equally well when initially colonized at
the same concentration (51). This was tested in the in vitro system by collecting
mucus from streptomycin treated mice and spiking EDL933 and EDL933 ppsA- pckAinto the collection solution. While the experiment went well early on, with both
strains growing to 107 CFU/ml, an eventual loss in EDL933 ppsA- pckA- shows that
the system is not yet perfect (Fig. 25). It is likely that the lower concentration of
mucin and mucus in the in vitro system results in less mono- and disaccharides being
made available by the anaerobe population for the EDL933 and EDL933 ppsA- pckAstrains to grow without the use of gluconeogenic substrates. Through limitation of
glycolytic substrates, this forced gluconeogenic shift would give the wildtype EDL933
a distinct advantage over EDL933 ppsA- pckA-, as the mutant cannot use
gluconeogenesis.
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At this point the novel in vitro model designed to mimic the mouse gut is
capable of cultivating the microbiota of the gut, but is only able to mimic certain
colonization experiments of E. coli competitions. In terms of mimicking the diversity
of the gut, only the relative abundance of certain members of the community is
affected by growth in the in vitro system. This may be overcome by slight alterations
to the system, such as an increase in the concentrations of mucin and/or mucus in
order to provide more nutrients to these populations. This may also have an effect on
the colonization experiments, as the key factor in these competitions is the availability
of specific substrates within specific niches. Even continued streptomycin treatment
within the in vitro system must be considered, as at this point streptomycin treatment
stops once removed from the mouse.

The streptomycin may be important for

maintaining a clear niche for some of these competing strains to move into, thus
resulting in the loss of a competitive advantage by not continuing streptomycin
treatment within the in vitro system. Furthermore, the early competitions involving
Nissle 1917 and MG1655 may be improved if the pre-colonizing strain is allowed to
remain in mice for a full 10 days prior to collection. The innate host immune system
may also be key in maintaining a balanced ecosystem within the gut (10, 13, 44, 54),
and as such may be important for the development of available niches to colonizing E.
coli strains. Thus, while the system is useful for observing the microbial community
of the mouse gut and the interactions with a single colonizing E. coli strain, the novel
in vitro gut model must be further improved in order to assess colonization ability of
individual E. coli strains.
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Table 1. Bacterial strains
E. coli strain

MG1655 StrR

Genotype/phenotype

Spontaneous streptomycin

Designation in

Source or

text

reference

MG1655

6

Nissle 1917

24, 44

EDL933

38

EDL933 ppsA-

42, 32

resistant mutant of MG1655
Nissle 1917 StrR

Spontaneous naladixic acid

NalR

resistant mutant of Nissle
1917 StrR

EDL933 StrR RifR

Spontaneous streptomycin
resistant mutant of EDL933

EDL933 StrR

Double deletion mutant of

ΔppsA ΔpckA::cam EDL933 Strr, carrying cat in
the pckA deletion and
retaining the pO157
virulence plasmid
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pckA- mutant

Table 2. Primers
Primer designation

Sequence

E.coli specific Cy-3 probe (red)

5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’

used for FISH
Eubacteria FitC probe (green)

5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’

used for FISH
16S V4 forward used for

5’-TCG TCG GCA GCG TCA GAT GTG TAT

community analysis sequencing

AAG A-3’

16S V4 reverse used for

5’-GTC TCG TGG GCT CGG AGA TGT GTA

community analysis sequencing

TAA G-3’
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Fig. 1 FISH images of the early in vitro system with (top) and without (bottom) E. coli
taken from day 0 samples. Both populations are intact. Red bacterial cells represent
E. coli labeled by the Cy3-probe, while green bacterial cells represent all Eubacteria
labeled by the FitC-probe.
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Fig. 2 FISH images of the early in vitro system with (top) and without (bottom) E. coli
taken from day 3 samples. When E. coli is present, it grows out of proportion and
takes over the system, and in both systems the rest of the population is mostly lost.
Red bacterial cells represent E. coli labeled by the Cy3-probe, while green bacterial
cells represent all Eubacteria labeled by the FitC-probe.
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Fig. 3 FISH images of the in vitro system with mucin concentration increased to
500ug/ml taken from day 5 (top) and day 6 (bottom) samples. While increasing the
mucin concentration improved the longevity of the system, most of the population is
still lost beyond day 5. Red bacterial cells represent E. coli labeled by the Cy3-probe,
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig. 4 FISH images of the in vitro system after adding 0.3% agarose without E. coli
taken from day 6 samples (top) and before adding agarose taken from day 6 samples
(bottom). Even without the E. coli present, agarose has improved the survivability of
the population within the in vitro system. Red bacterial cells represent E. coli labeled
by the Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the
FitC-probe.
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Fig. 5 FISH image taken from in vitro experiment in which mice were precolonized
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in
vitro samples. The E. coli is no longer growing to take over the entire population, and
the rest of the organisms are able to survive and form biofilm communities. Red
bacterial cells represent E. coli labeled by the Cy3-probe, while green bacterial cells
represent all Eubacteria labeled by the FitC-probe.
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Fig. 6 Comparison of a FISH imaged biofilm of in vivo samples from a mouse
colonized with Nissle 1917 for 10 days (left) and in vitro samples in which a mouse
was precolonized with Nissle 1917 for 3 days prior to being collected into the in vitro
system, taken from day 7 in vitro samples (right).
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Fig. 7 FISH images taken from in vitro samples on day 7 in which either no mucin
(above) or no Cleland’s reagent (below) was added. These images show the
importance of the mucin and Cleland’s reagent in preserving the community within
the in vitro system. Red bacterial cells represent E. coli labeled by the Cy3-probe,
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig. 8 7 FISH images taken from in vitro samples on day 7 in which either no mucus
(above) or only 0.2 mg/ml mucus (below) was added. Decreasing the mucus
concentration results in a loss of a majority of the population, with E. coli taking over
as the majority of surviving cells. Red bacterial cells represent E. coli labeled by the
Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the FitCprobe.
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Fig. 9 Bar plot showing relative abundance of major families in mice colonized with
Nissle 1917 for 10 days (green) and in vitro samples in which mice were precolonized
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in
vitro samples. While there seems to be a difference in terms of s24-7 and
Deferribacteracaea, the differences are not statistically relevant and both mice and in
vitro samples have similar levels of representation from the same major families.
Error bars indicate standard error of the mean.
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Fig. 10 Stacked bar plot showing relative abundance of Nissle 1917 in vivo (left) and
in vitro (right) at the family level. The stacked bars are showing the same data as is
seen in the relative abundance graphs, but separates the individual samples to better
highlight the variation amongst hosts.
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Fig. 11 Bar plot showing relative abundance of major phyla in mice colonized with
Nissle 1917 for 10 days (green) and in vitro samples in which mice were precolonized
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in
vitro samples. None of the differences seen are enough to be statistically significant
(P > 0.05). Error bars indicate standard error of the mean.

108

Fig. 12 Stacked bar plot showing relative abundance of Nissle 1917 in vivo (left) and
in vitro (right) at the phylum level. The stacked bars are showing the same data as is
seen in the relative abundance graphs, but separates the individual samples to better
highlight the variation amongst hosts.
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Fig. 13 Crude rarefaction curves of Nissle 1917 samples used to compare richness of
diversity in vitro (top) and in vivo (bottom).
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Fig. 14 FISH image of an in vitro sample in which the cecal mucus of an untreated
“conventional” mouse was collected into the in vitro system, taken from day 7 in vitro
sample. Diversity in the cell morphologies can be seen amongst the organisms
present. Red bacterial cells represent E. coli labeled by the Cy3-probe, while green
bacterial cells represent all Eubacteria labeled by the FitC-probe.
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Fig. 15 Bar plot showing relative abundance of major families in untreated
“conventional” mice (white) and in vitro samples in which untreated “conventional”
mice were collected into the in vitro system (blue), taken from day 7 in vitro samples.
Error bars indicate standard error of the mean. Differences between the in vitro and in
vivo samples were seen in the Bacteroideaceae (P < 0.0001), Deferribacteraceae (P <
0.001), and Lachnospiraceae (P < 0.001).
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Fig. 16 Stacked bar plot showing relative abundance of conventional in vivo (left) and
in vitro (right) at the family level. The stacked bars are showing the same data as is
seen in the relative abundance graphs, but separates the individual samples to better
highlight the variation amongst hosts.
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Fig. 17 Bar plot showing relative abundance of major phyla in untreated mice (white)
and in vitro samples in which untreated mice collected into the in vitro system (blue),
taken from day 7 in vitro samples. Error bars indicate standard error of the mean. At
the phylum level, Bacteroidetes were more abundant relative to Firmicutes in the
conventional in vitro samples compared to what was seen in the in vivo samples, and
Deferribacteres had little representation in vitro. The differences seen between each
phylum; Bacteroidetes, Deferribacteres, and Firmicutes, are statistically significant (P
< 0.001 for each).
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Fig. 18 Stacked bar plot showing relative abundance of conventional in vivo (left) and
in vitro (right) at the phylum level. The stacked bars are showing the same data as is
seen in the relative abundance graphs, but separates the individual samples to better
highlight the variation amongst hosts.
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Fig. 19 Crude rarefaction curves of conventional samples used to compare richness of
diversity in vitro (top) and in vivo (bottom).
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Fig. 20 Competition experiments of Nissle 1917 early vs Nissle 1917 late: in vivo
(top) and in vitro (bottom). This shows that colonization resistance is seen in vitro just
as it is seen in mice.
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Fig. 21 Competition experiments of MG1655 early vs MG1655 late: in vivo (top) and
in vitro (bottom). This shows that colonization resistance is seen in vitro just as it is
seen in mice.
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Fig. 22 Competition experiments of Nissle 1917 early vs MG1655 late: in vivo (top)
and in vitro (bottom). This shows that not all competitions are mimicked perfectly in
the in vitro system, possibly due to limitation of nutrients.
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Fig. 23 Competition experiments of MG1655 early vs Nissle 1917 late: in vivo (top)
and in vitro (bottom). This shows that competitions in which MG1655 is fed early and
Nissle 1917 is fed or spiked in late are similar in mice and in vitro.

120

10

Log10 CFU/gram feces

9
8
7
6
5
4
3
2
1
0

2

4

6

8

10

12

14

16

18

20

22

Days

Fig. 24 Competition experiments of Nissle 1917 early vs EDL933 wildtype and
EDL933 pckA-ppsA- late: in vivo (top) and in vitro (bottom). Another competition in
which the in vitro system mimics what is seen in mice, as the EDL933 gluconeogenic
mutant cannot compete and falls out of the system while the wildtype is maintained.
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Fig. 25 Competition experiments of EDL933 wildtype vs EDL933 pckA-ppsA-: in vivo
(top) and in vitro (bottom). This competition shows that the in vitro system is unable
to mimic the mouse perfectly as EDL933 does not switch to gluconeogenic substrates
in mice that were not pre-colonized with Nissle 1917, but does switch in the in vitro
system. Again likely due to limitation of nutrients.
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